Navigation Links
Archimedes Pharma Launches Lazanda® - the Only Fentanyl Nasal Spray for the Management of Breakthrough Pain in Cancer in the U.S.
Date:10/17/2011

ence at 30 minutes (SPID30). More than 500 patients evaluated in the clinical trial program (which included three phase III clinical trials) contributed to the understanding of the tolerability and safety profile of Lazanda. The most common adverse events associated with Lazanda were consistent with opioid treatment and included vomiting, nausea, pyrexia (fever), and constipation.IMPORTANT SAFETY INFORMATION WARNINGS: POTENTIAL FOR ABUSE and IMPORTANCE OF PROPER PATIENT SELECTIONLazanda® contains fentanyl, an opioid agonist and a Schedule II controlled substance, with an abuse liability similar to other opioid analgesics. Lazanda can be abused in a manner similar to other opioid agonists, legal or illicit. Consider the potential for abuse when prescribing or dispensing Lazanda in situations where the physician or pharmacist is concerned about an increased risk of misuse, abuse, or diversion. Schedule II opioid substances, which include morphine, oxycodone, hydromorphone, oxymorphone, and methadone, have the highest potential for abuse and risk of fatal overdose due to respiratory depression. Serious adverse events, including deaths, in patients treated with other oral transmucosal fentanyl products have been reported.  Deaths occurred as a result of improper patient selection (e.g., use in opioid non-tolerant patients) and/or improper dosing. The substitution of Lazanda for any other fentanyl product may result in fatal overdose.Lazanda is indicated only for the management of breakthrough pain in cancer patients 18 years of age and older who are already receiving and who are tolerant to opioid therapy for their underlying persistent cancer pain. Patients considered opioid tolerant are those who are taking at least 60 mg of oral morphine/day, 25 mcg of transdermal fentanyl/hour, 30 mg of oxycodone/day, 8 mg oral hydromorphone/day, 25 mg oral oxymorphone/day, or an equianalgesic dose of another opioid for one week or longer. Lazanda is
'/>"/>

SOURCE Archimedes Pharma Ltd.
Copyright©2010 PR Newswire.
All rights reserved

Page: 1 2 3 4 5 6 7

Related medicine technology :

1. Archimedes Pharma Announces Publication of Long-Term Safety and Tolerability Clinical Study of Fentanyl Pectin Nasal Spray (FPNS) in the Journal of Opioid Management
2. Archimedes Pharma Announces Publication of a Pivotal Clinical Study of Fentanyl Pectin Nasal Spray (FPNS) in Pain, the Peer-Reviewed Journal from the International Association for the Study of Pain
3. Archimedes Pharma Receives CHMP Positive Opinion for PecFent(R) for the Treatment of Breakthrough Cancer Pain
4. Archimedes Pharma Announces Successful Proof-of-Concept Results on Two Intranasal Development Projects
5. Novo Nordisk A/S: PharmaVitae Profile
6. Auxilium Pharmaceuticals to Announce Third Quarter 2011 Results and Conduct Conference Call on Monday, October 31, 2011
7. Par Pharmaceutical Files Declaratory Judgment to Protect First Amendment Rights to Disseminate Truthful Information Regarding Megace® ES
8. Reata Pharmaceuticals Adds Executives to Management Team and Board of Directors
9. Access Pharmaceuticals Updates MuGard Website with New Video Featuring Clinical Feedback and Manufacturing Footage
10. CVS/pharmacy Ready to Provide Assistance During Medicare Part D Annual Enrollment Period
11. ShangPharma Corporation Announces Shareholder Resolutions Adopted at 2011 Annual General Meeting
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:7/28/2014)...  Air Products (NYSE: APD ) understands ... vital to any healthcare facility. This understanding has driven ... the efficiency of its oxygen supply systems, but also ... systems for emergency oxygen supply and high ... the 51 st ASHE Annual Conference & ...
(Date:7/28/2014)... Research and Markets  has announced the addition ... report to their offering. http://photos.prnewswire.com/prnh/20130307/600769 ... to inflammation and pain in the human body,s joints such ... causes inflammation of the tissues that surround the joints and ... RA begin slowly, usually just mild pain around the joints ...
(Date:7/28/2014)... July 28, 2014  TNI BioTech, Inc. (OTCQB: ... focused on the development, marketing and distribution of ... definitive proxy materials with the Securities and Exchange ... of Shareholders to be held on Thursday, September ... The record date for determining those shareholders eligible ...
Breaking Medicine Technology:Air Products Highlights Its Medical Oxygen Supply Systems for Emergency Oxygen Supply and Reduced Oxygen Loss at ASHE 2Air Products Highlights Its Medical Oxygen Supply Systems for Emergency Oxygen Supply and Reduced Oxygen Loss at ASHE 3Global Rheumatoid Arthritis Drugs Market 2014-2018 2TNI BioTech, Inc., Files Definitive Proxy Materials; Mails Letter Urging Shareholders to Vote the Proxy Card 2TNI BioTech, Inc., Files Definitive Proxy Materials; Mails Letter Urging Shareholders to Vote the Proxy Card 3
... Institute and Gallo Research Center today announced ... (SoRI-9409) will be published in the December ... publication is available online,today at the journal,s ... that,causes selective and long-lasting reduction in ethanol ...
... ALTO, Calif., Sept. 11 Jazz,Pharmaceuticals, Inc. (Nasdaq: ... participation in the first Phase III pivotal clinical trial,of ... The JZP-6 Phase III clinical trial program includes two ... patients at 65 centers in the U.S. The second ...
Cached Medicine Technology:Novel Compound Shows Promise for Treatment of Alcoholism 2Novel Compound Shows Promise for Treatment of Alcoholism 3Novel Compound Shows Promise for Treatment of Alcoholism 4Jazz Pharmaceuticals, Inc. Announces Final Patient Has Completed Phase III Clinical Trial of Sodium Oxybate to Treat Fibromyalgia 2Jazz Pharmaceuticals, Inc. Announces Final Patient Has Completed Phase III Clinical Trial of Sodium Oxybate to Treat Fibromyalgia 3
(Date:7/28/2014)... Co (PRWEB) July 28, 2014 Drorit ... has unveiled new plans to raise investment capital through ... 24/7 fitness concept in the United States. , According ... popularity of 24/7 fitness centers provide a great window ... this rapidly expanding space. In addition to this, Silverman ...
(Date:7/28/2014)... 2014 "Fist bumping" transmits significantly fewer bacteria ... the cultural expectation of hand-to-hand contact between patients ... the August issue of the American Journal ... the Association for Professionals in Infection Control and ... Institute of Biological, Environmental, and Rural Sciences at ...
(Date:7/28/2014)... 2014 The Wireline Services Market in Europe ... with analysis and forecast of revenue. The Wireline services market ... in 2013 to $2.4 billion by 2019, at a CAGR ... TOC of the Wireline Services Market in Europe report, to ... provides a glimpse of the segmentation in the European Wireline ...
(Date:7/28/2014)... HealthDay Reporter MONDAY, July ... to have a slightly increased risk of potentially fatal ... researchers report. Doctors have previously suspected that babies ... risk of deep vein thrombosis and pulmonary embolism, two ... the researchers noted in background information. This new ...
(Date:7/28/2014)... The Oneida Indian Nation today announced ... of accompanying PGA TOUR players will be teeing up ... Begay III for the seventh annual Notah Begay III ... Casino ’s Atunyote® Golf Club on Wednesday, August 27, ... Dufner, Jimmy Walker, Jonas Blixt, Angel Cabrera and Louis ...
Breaking Medicine News(10 mins):Health News:Pro Bodybuilder Drorit Silverman Confirms Plans to Raise Money for Investment in the Popular 24/7 Fitness Concept 2Health News:Fist-bumping beats germ-spreading handshake, study reports 2Health News:Europe Wireline Services Market is Expected to Reach $2.4 billion in 2019 - New Report by MicroMarket Monitor 2Health News:Europe Wireline Services Market is Expected to Reach $2.4 billion in 2019 - New Report by MicroMarket Monitor 3Health News:Europe Wireline Services Market is Expected to Reach $2.4 billion in 2019 - New Report by MicroMarket Monitor 4Health News:Preemies May Have Higher Risk of Blood Clots, Even as Adults 2Health News:Preemies May Have Higher Risk of Blood Clots, Even as Adults 3Health News:Turning Stone Announces that Tiger Woods and Fellow Golfing Elites Will Play at the Seventh Annual Notah Begay III Foundation Challenge 2Health News:Turning Stone Announces that Tiger Woods and Fellow Golfing Elites Will Play at the Seventh Annual Notah Begay III Foundation Challenge 3Health News:Turning Stone Announces that Tiger Woods and Fellow Golfing Elites Will Play at the Seventh Annual Notah Begay III Foundation Challenge 4Health News:Turning Stone Announces that Tiger Woods and Fellow Golfing Elites Will Play at the Seventh Annual Notah Begay III Foundation Challenge 5
... , ... embrace new technology. , ... MA (PRWEB) January 11, 2010 -- SonRidge, LLC, a catering and chef supplies company located ... for their clients in the food industry. What they discovered was an innovative resolution that ...
... ... and marketer of all-natural sunscreen products launched their website at solaraegis.com. , ... (PRWEB) January 13, 2010 -- ... products launched their website at www.solaraegis.com ., , , , ,"The site ...
... ... and financial security pet health insurance makes sense. Veterinarians once skeptical to the value ... insurance. , ... PA (PRWEB) January 14, 2010 -- Pet Health Insurance in the United States and ...
... ... stresses importance of greater awareness of brain injuries and serious lifelong implications for victims ... San Francisco, ... Year,s Day, in which top-ranked American snowboarder Kevin Pearce suffered a severe brain injury ...
... led by Professor Eduardo Franco, Director of McGill University,s ... colleagues from McGill and Universit de Montral/Centre Hospitalier de ... per cent) of young adults in a new sexual ... nearly half (44 per cent) were infected with an ...
... , , , NEW YORK ... a leading provider of software to public retirement organizations, announced ... System implementation for the State Teachers Retirements System of ... as a replacement to their legacy contributions, pension, disbursement, and ...
Cached Medicine News:Health News:Insulated Transport Containers Go Green 2Health News:SolarAegis, LLC. Website Helps You Have Fun In the Sun, Safely 2Health News:Pet Health Insurance Grows as Pets Live Longer and Healthier Lives 2Health News:Pet Health Insurance Grows as Pets Live Longer and Healthier Lives 3Health News:Pet Health Insurance Grows as Pets Live Longer and Healthier Lives 4Health News:Pet Health Insurance Grows as Pets Live Longer and Healthier Lives 5Health News:Snowboarding Accident Provides Tragic Reminder of Serious Risk of Brain Injuries in Athletic and Occupational Environments 2Health News:McGill-CHUM study: 56 percent of young adults in a new sexual relationship infected with HPV 2Health News:State Teachers Retirement System of Ohio Goes Live on V3 Benefits Administration System 2Health News:State Teachers Retirement System of Ohio Goes Live on V3 Benefits Administration System 3
... is a national reference laboratory and a ... development. ARUP offers an extensive test menu ... in clinical and anatomic pathology. Owned by ... include more than half of the nation's ...
... is a national reference laboratory and a ... development. ARUP offers an extensive test menu ... in clinical and anatomic pathology. Owned by ... include more than half of the nation's ...
... ARUP Laboratories is a national reference laboratory ... research and development. ARUP offers an extensive ... medical tests in clinical and anatomic pathology. ... Laboratories' clients include more than half of ...
... national reference laboratory and a worldwide leader ... offers an extensive test menu of highly ... and anatomic pathology. Owned by the University ... than half of the nation's university teaching ...
Medicine Products: